Vimarsana
Biggest News Aggregation in the World

Corey Merrill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Corey Merrill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Corey Merrill Today - Breaking & Trending Today

Everyone is a Winner in Weekend Tourney - Vimarsana News

Everyone is a Winner in Weekend Tourney

A Saturday afternoon wiffle ball game at Monadnock Park served as a great introduction to the city’s latest neighbors at two Hope 2 Freedom Recovery Homes (H2FRH) residences, Corey’s Place

U.S. ruling gives Sackler family, owners of Purdue Pharma, immunity from opioid lawsuits - Vimarsana News

U.S. ruling gives Sackler family, owners of Purdue Pharma, immunity from opioid lawsuits

The Sackler family, the wealthy owners of Purdue Pharma, will be shielded from future lawsuits related to the opioid epidemic under a plan approved by a U.S. federal appeals court.

Source: cbc.ca
Ruling Clears Way for Purdue Pharma to Settle Opioid Claims, Protects Sacklers from Lawsuits - Vimarsana News

Ruling Clears Way for Purdue Pharma to Settle Opioid Claims, Protects Sacklers from Lawsuits

A federal appeals court cleared the way for the maker of OxyContin to settle thousands of legal claims tied to the opioid epidemic while shielding the wealthy owners of Purdue Pharma, the Sackler family, from future lawsuits.

Sackler family - the owners of Purdue Pharma - are given IMMUNITY in exchange for $6 billion - Vimarsana News

Sackler family - the owners of Purdue Pharma - are given IMMUNITY in exchange for $6 billion

The Sacklers have been given immunity from civil lawsuits over the opioid crisis in exchange for $6billion that will go towards treatments for addiction.

New ruling paves way for Purdue Pharma reorg plan with Sacklers shielded - Vimarsana News

New ruling paves way for Purdue Pharma reorg plan with Sacklers shielded

A federal appeals court on Tuesday eliminated the main barrier to Purdue Pharma’s bankruptcy reorganization plan that shields members of the Sackler family from future lawsuits.